Money Eli Lilly’s blowout quarter should quiet investor concerns about the stock 6 mins read Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster
Money Eli Lilly’s second quarter eases Zepound pricing fears and suggests it’s gaining ground in weight loss race 2 mins read Eli Lilly shares are surging after it posted impressive second-quarter results, helped by a
Finanance Alphabet taps Eli Lilly’s Anat Ashkenazi as new CFO 1 min read A view of Google Headquarters in Mountain View, California, United States on April 16,
Money Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings 2 mins read Each weekday the CNBC Investing Club with Jim Cramer retains a “Morning Conference” livestream
Money Why Eli Lilly’s earnings are no sure thing for traders despite obesity drug momentum 3 mins read Eli Lilly appears to be earning as much of its popular weight problems and
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers 1 min read